Despite the rising popularity of the minimally invasive laparoscopic option, open nephron-sparing surgery is still seen by many experts as the 'gold standard' for open surgery for kidney tumors and should remain the first choice for many patients. This challenges the idea that less-invasive therapies are always more desirable than open surgery. Whi

This updated edition offers guidance on the application of robotic surgery in urology. Each technique is described in detail, with careful explanation of the different surgical steps The book brings together leading robotic surgeons from around the world and utilises their knowledge once again to update and provide a manual that covers all the oncologic and reconstructive procedures in urologic surgery that are performed with robotic assistance This book serves as an ideal reference work for all urologists and should contribute in supporting new robotic teams

Robotic Urologic Surgery, Second Edition is an updated and revised technical manual focusing on the various robotic approaches to robotic urologic surgical procedures. This book provides instructions on how to develop a successful robotics program, learn the various techniques, and improve outcomes. It also aids the reader with helpful hints to avoid pitfalls. Robotic Urologic Surgery, Second Edition includes up-to-date contributions from leading robotic urologic surgeons from around the world. The detailed body of data which this book provides is supported by schematic diagrams and anatomic photographs to illustrate the concept being discussed. Robotic Urologic Surgery, Second Edition is an essential guide for all urologists as a reference to establish a robotics program, refine their surgical technique, and provide information to patients.

**Selected for Doody's Core Titles® 2024 in Urology**Single-Port Robotic Surgery in Urology: The New Beginning After the Advent of Dedicated Platforms describes the novel field of robotic single-port urologic surgery. Recent advances in surgical robotics combined with the pursuit to reduce the invasiveness of laparoscopic surgery have led to the development of novel robotic platforms specifically designed for single-port surgery. This reference summarizes the state-of-the-art of robotic single-port urologic surgery. Coverage takes a three-part approach, providing a description of the technological evolution which led to the advent of novel platforms specifically designed for single-port surgery, describing the urological procedures that can be performed, and outcomes and potential drawbacks. - Provides a description of the current status of single-port robotic urologic surgery performed using novel dedicated platforms - Expands understanding on why single-port is better than the standard multi-arms robotic approach, highlighting an analysis of surgical steps - Summarizes data about each intervention, including pooled comparative analyses, to provide the most evidence-based examination possible

This updated volume provides a comprehensive guide to the recent developments of digital and intelligent technologies related to genitourinary surgery. New topics include the adaptation of simulators, training programs, standardized credentialing, evidence-based practice, as well as the economics of robotic surgery. The impact on public and global health is also covered. Robotics in Genitourinary Surgery aims to help surgeons and patients adopt the techniques and procedures discussed, and in turn educate and expand research activities within the field.

This latest book in the Management of Urology Series provides insight into how to appropriately manage patients undergoing pelvic robotic urological surgery for renal cancer. Extensive guidance is provided on how to perform a range of procedures including the retroperitoneal renal approach along with information on how to utilize the latest robots effectively. Cases are also presented on how to best manage complications associated with partial nephrectomy. Each chapter also contains learning objectives to assist the reader in extrapolating the key information covered. Robotic Surgery for Renal Cancer is an up-to-date overview of the latest techniques utilized in this field along with potential management strategies for these patients, making it a critical resource for urologists, oncologists, and specialist nurses.

Kidney cancer is the 10th most common cancer in Europe with overall mortality rates increasing until the late 1980s and early 1990s and thereafter, stabilised. Until recently, renal cell carcinoma (RCC) was thought to represent a monomorphic disease; however, modern genetic characterisation has demonstrated different subtypes with specific cell types and molecular metabolism. Imaging diagnostic methods are basic for staging and for new treatment strategies. Moreover, tumour biopsy has been reintroduced in the diagnostic armamentarium, mainly in patients with small masses but also when disseminated tumours need to be treated with new target therapies. Although TNM stage, Fuhrman grade and Eastern Oncology Group (ECOG) performance status are the most recognised prognostic factor in RCC, active research continues to determine new prognostic factors to classify different risks for death from RCC. Laparoscopy has gained widespread popularity because of a less morbidity and a faster post-operative convalescence. Partial laparoscopic nephrectomy is a demanding operation that can be made depending on the experience of the surgeon, the size or location of the tumour in the kidney. New robotic approaches are being introduced for nephron sparing surgery. Conversely, cardiac bypass can be necessary for resection of tumours with thrombus extending into the inferior vena cava above the level of hepatic veins. With the advent of modern ablative energies (cryotherapy or radiofrequency) for renal tumours in selected patients with percutaneous or laparoscopic techniques, it is now possible to achieve long cancer specific survival with decreased morbidity. A need for standardisation of follow-up after surgery with lifelong protocols has been recognised in last years. Finally, angiogenesis inhibitors have demonstrated a high probability of disease control in patients with metastatic renal carcinomas. Their indication as adjuvant in local advanced tumours as well as the role of nephrectomy in patients with metastatic disease is being evaluated in current clinical trials.